Unlock insights into ADC development with HUB Organoids’ factsheet on patient-derived organoids. Discover how advanced 3D tumour models are transforming preclinical testing and supporting safer, more effective antibody-drug conjugates.

What you’ll learn:

• How organoids outperform traditional preclinical models for ADCs
• Strategies for evaluating efficacy, safety, and biomarker discovery
• Real-world case studies for optimising drug development decisions
• Download to advance your ADC research with cutting-edge, patient-relevant data

Brought to you by